Filing Details
- Accession Number:
- 0001209191-14-039647
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-06 17:12:32
- Reporting Period:
- 2014-06-05
- Filing Date:
- 2014-06-06
- Accepted Time:
- 2014-06-06 17:12:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1123979 | Senomyx Inc | SNMX | Services-Commercial Physical & Biological Research (8731) | 330843840 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1286100 | John Poyhonen | 4767 Nexus Center Drive San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-05 | 37,600 | $6.02 | 124,356 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-06-05 | 37,600 | $8.00 | 86,756 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2014-06-05 | 37,600 | $0.00 | 37,600 | $6.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-06-24 | No | 4 | M | Direct |
Footnotes
- The options exercised were scheduled to expire on June 24, 2014.
- Includes 133 shares and 5,907 shares of Common Stock that were acquired by the Reporting Person on 8/31/13 and 2/28/14, respectively, pursuant to the Issuer's Employee Stock Purchase Plan.
- Reported transaction occurred pursuant to Rule 10B5-1 Plan.
- In addition to the 86,756 shares of common stock beneficially owned, the Reporting Person also holds outstanding options to purchase 1,699,250 shares of common stock.
- The shares subject to the option are fully vested.